Illumina Consumables — Total Revenue decreased by 4.2% to $797.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from $768.00M to $797.00M. Over 4 years (FY 2021 to FY 2025), Consumables — Total Revenue shows relatively stable performance with a 0.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates higher utilization of the installed base of instruments and growing customer demand for ongoing testing or research services.
This metric represents the total gross revenue generated from the sale of recurring product components required to opera...
Comparable to 'Recurring Revenue' or 'Consumables Revenue' reported by other life science tools and diagnostic equipment manufacturers.
ilmn_segment_consumables_total_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $778.00M | $794.00M | $870.00M | $853.00M | $813.00M | $796.00M | $763.00M | $764.00M | $804.00M | $760.00M | $756.00M | $762.00M | $807.00M | $807.00M | $779.00M | $768.00M | $811.00M | $816.00M | $832.00M | $797.00M |
| QoQ Change | — | +2.1% | +9.6% | -2.0% | -4.7% | -2.1% | -4.1% | +0.1% | +5.2% | -5.5% | -0.5% | +0.8% | +5.9% | +0.0% | -3.5% | -1.4% | +5.6% | +0.6% | +2.0% | -4.2% |
| YoY Change | — | — | — | — | +4.5% | +0.3% | -12.3% | -10.4% | -1.1% | -4.5% | -0.9% | -0.3% | +0.4% | +6.2% | +3.0% | +0.8% | +0.5% | +1.1% | +6.8% | +3.8% |